Barclays Remains a Buy on Sabre Insurance Group plc (SBRE)

Barclays' Ivan Bokhmat reiterated a Buy rating on Sabre Insurance Group (SBRE) with a £1.96 price target. The company reported Q2 revenue of £112.12M and net profit of £17.94M, up from £50.95M and £9.46M respectively last year. Analyst consensus is Moderate Buy with a £1.91 price target. Insider sentiment is negative.

Original reporting
Published Sep 5, 2026, 7:17 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 6, 2026, 12:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Barclays Remains a Buy on Sabre Insurance Group plc (SBRE) — source image
Decision brief

The 30-second read

Med
01

Why it matters

The new Buy rating and price target may attract short‑term buying, but insider sell‑off could limit gains.

02

Market read

Analyst upgrade provides a fresh catalyst for SBRE.L; investors should weigh against negative insider sentiment.

03

What to watch

Potential macro‑economic headwinds for insurers could temper upside.

Relevance 7/10Novelty 7/10Timing: today

Background

Barclays analyst coverage includes peers in the UK insurance market; the rating aligns with sector optimism.

Market effects

Positive signal for UK insurance sector, may boost peers like Aviva and Hiscox.

Supports broader UK market sentiment in financial services.

Limited to UK insurers; minimal global impact.

Counterpoint

Insider selling sentiment is negative, suggesting caution despite the upgrade.

Key entities

  • Sabre Insurance Group plc

    UK‑listed insurer receiving a Buy rating from Barclays.

  • Ivan Bokhmat

    Barclays analyst covering the financial sector.

Related articles

$SABRMedAI 8/10

Why Sabre (SABR) Stock Is Up Today

Sabre (SABR) shares rose about 6% after the company reported Q2 2026 results: revenue of $712 million (+4% YoY) and normalized adjusted EBITDA of $151 million (+19%). Sabre raised its full-year pro forma adjusted EBITDA outlook to about $600 million and cited new Airline Technology client wins including Hawaiian, Lao Airlines, and Air Tanzania. Shares closed at $2.21 (+7.2%).

$SABRMedAI 8/10

Sabre (SABR) Q2 2026 Earnings Call Transcript

Sabre (SABR) reported Q2 2026 results ahead of expectations, with revenue up 4% to $712 million and normalized adjusted EBITDA up 19% year-on-year to $151 million, alongside positive free cash flow. The company raised full-year 2026 guidance for pro forma adjusted EBITDA and free cash flow, citing stronger air distribution bookings, hotel revenue growth, and payments momentum.

$SABRMedAI 8/10

Why Sabre (SABR) Stock Is Up Today

Sabre (NASDAQ: SABR) shares rose about 6% after the company reported Q2 2026 revenue of $712 million (+4% y/y) and normalized adjusted EBITDA of $151 million (+19%). Sabre raised full-year pro forma adjusted EBITDA outlook to about $600 million and cited new Airline Technology client wins, including Hawaiian and Lao Airlines, plus Air Tanzania selecting its platform. Shares closed at $2.21 (+7.2%).

$SABRMed

Why Sabre (SABR) Stock Is Down Today

Sabre (NASDAQ: SABR) shares fell 7.8% to $2.07 after mixed Q2 results. Revenue rose 4% to $712 million, but an adjusted loss was wider than expected. Management raised full-year pro forma adjusted EBITDA to about $600 million and free cash flow to about negative $65 million, while reaffirming low-to-mid single-digit revenue growth.

$SABRMed

Sabre Corp (SABR): Results of Operations and Financial Condition

Sabre Corp (SABR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Sabre reports second quarter 2026 results Exceeds second quarter guidance; raises full year 2026 Pro Forma Adjusted EBITDA and Free Cash Flow guidance Business Highlights: • Exceeded second quarter revenue, Pro Forma Adjusted EBITDA and air distribution bookings guidance, reflect